Zydus Lifesciences says its Zydus Biologics injectable plant in Ahmedabad was inspected by the USFDA from April 27 to May 5, 2026. The audit resulted in seven observations, though the company emphasized that there were no data integrity issues. Zydus is now in discussions with the USFDA to address the findings promptly and maintain compliance.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
